,,ii  #aaith ,,congress  #b;d ,session  
,s4 #dccb  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,april #af     
7legislative day1 ,april #ad71 #bjbf,ms4
 ,hassan 7for herself and ,mr4 ,budd7   
introduced the following bill2 which was
 read twice and referred to the         
,committee on ,health1 ,education1      
,labor1 and ,pensions  ,a ,,bill  ,to   
require the ,secretary of ,health and   
,human ,services to make determinations 
of the exclusivity periods for which    
licensed biological products are        
eligible4  #a4 ,short title ,this ,act  
may be cited as the ,medication         
,competition ,act4  #b4 ,determination  
of reference product exclusivity        
,section #cea7k77#i77;,a77iv7 of the    
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bfb7k77#i77;,a77iv77 is      
amended-- 7#a7 by inserting determine   
any applicable exclusivity period under 
paragraph 7#f7 or 7#g71 and shall after 
the ,secretary shall2  7#b7 by striking 
the period at the end and inserting 1 as

 follows32 and  7#c7 by adding at the   
end the following3  7,i7 ,exclusivity   
for first interchangeable biological    
products  7aa7 ,products licensed on or 
after the date of enactment ,with       
respect to a biological product licensed
 under this subsection on or after the  
date of enactment of the ,medication    
,competition ,act1 the ,secretary shall 
include on the list published under this
 subparagraph any applicable exclusivity
 period under paragraph 7#f71 not later 
than #cj days after the earliest date on
 which an expiration date of such an    
exclusivity period can be known pursuant
 to paragraph 7#f74  7bb7 ,products     
licensed before the date of enactment   
,with respect to a biological product   
licensed under this subsection before   
the date of enactment of the ,medication
 ,competition ,act1 the ,secretary shall
 include on the list published under    
this subparagraph any applicable        
exclusivity period under paragraph 7#f71
 not later than #cj days after the later

 of such date of enactment or the       
earliest date on which an expiration    
date of such an exclusivity period can  
be known pursuant to paragraph 7#f74    
7,,ii7 ,exclusivity for reference       
products  7aa7 ,products licensed on or 
after the date of enactment ,with       
respect to a biological product licensed
 under subsection 7a7 on or after the   
date of enactment of the ,medication    
,competition ,act1 the ,secretary shall 
include on the list published under this
 subparagraph the expiration date of any
 exclusivity period under paragraph     
7#g71 not later than #cj days after     
licensure of the biological product4    
7bb7 ,products licensed before the date 
of enactment ,with respect to any       
biological product licensed under       
subsection 7a7 before the date of       
enactment of the ,medication            
,competition ,act1 the ,secretary shall 
include on the list published under this
 subparagraph the expiration date of any
 exclusivity period under paragraph     

7#g71 not later than #b years after such
 date of enactment4  4